Contact this trialFirst, we need to learn more about you.
NMDA receptor antagonist
IM Ketamine vs Midazolam for Suicidal Thoughts
Recruiting3 awardsPhase 4
New York, New York
This trial proposes the use of ketamine to relieve suicidal thoughts in depressed patients within hours of treatment. If successful, this would be a scalable intervention for busy emergency clinicians to implement.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.